Market Access has top priority in most pharmaceutical company’s value chain. However, its meaning is unclear with a wide range of company specific definitions.
pharmaLevers is proposing the following definition:
“Market Access is a stakeholder tailored, multidisciplinary, aligned approach to accelerate market uptake by optimizing value demonstration, pricing and reimbursement”
Market Access involves different functional areas such as: Regulatory Affairs, HTA, Health Economy, Pricing & Reimbursement, Governmental and Public Affairs, Key Account Management, Communication and of course Marketing & Sales. As a consequence variations, duplications and GAP’s in Market Access activities may occur, resulting in suboptimal market uptake and use of unnecessary resources.
pharmaLevers is helping clients to:
translate current business into a market access organization
learn how to structure the internal process to meet payer and decision makers needs
align and build synergies of functional activities